Structures by: Tulyabaev A. R.
Total: 21
C18H22FNO4
C18H22FNO4
CrystEngComm (2018) 20, 23 3207
a=12.6170(10)Å b=6.6369(5)Å c=19.1450(17)Å
α=90° β=90° γ=90°
11-(4-fluorophenyl)-8,9,13,14-tetraoxa-11-azaspiro[6.7]tetradecane
C15H20FNO4
CrystEngComm (2018) 20, 23 3207
a=5.7993(5)Å b=25.037(3)Å c=10.1500(11)Å
α=90.00° β=100.329(11)° γ=90.00°
C19H25NO5
C19H25NO5
CrystEngComm (2018) 20, 23 3207
a=12.4037(10)Å b=14.5530(17)Å c=9.9903(8)Å
α=90.0° β=103.023(8)° γ=90.0°
C19H25NO4
C19H25NO4
CrystEngComm (2018) 20, 23 3207
a=20.1905(16)Å b=6.6712(4)Å c=12.9057(9)Å
α=90.0° β=106.432(8)° γ=90.0°
C18H26FNO4
C18H26FNO4
CrystEngComm (2018) 20, 23 3207
a=12.8989(17)Å b=5.8609(5)Å c=13.5007(19)Å
α=90° β=116.417(17)° γ=90°
10-(4-fluorophenyl)-7,8,12,13-tetraoxa-10-azaspiro[5.7]tridecane
C14H18FNO4
CrystEngComm (2018) 20, 23 3207
a=12.4485(6)Å b=10.2927(6)Å c=21.8055(10)Å
α=90° β=90° γ=90°
C23H22EuN2O13P
C23H22EuN2O13P
CrystEngComm (2018) 20, 23 3207
a=11.6303(12)Å b=17.6259(18)Å c=14.8517(15)Å
α=90° β=91.363(2)° γ=90°
6'-phenylspiro[adamantane-2,2'-[1,3,4,8,6]tetraoxazocane]
C18H23NO4
CrystEngComm (2018) 20, 23 3207
a=12.735(3)Å b=6.5866(9)Å c=18.883(3)Å
α=90° β=90° γ=90°
C18H26ClNO4
C18H26ClNO4
CrystEngComm (2018) 20, 23 3207
a=12.146(2)Å b=6.0004(7)Å c=14.022(3)Å
α=90° β=112.03(2)° γ=90°
C16H22FNO4
C16H22FNO4
CrystEngComm (2018) 20, 23 3207
a=5.6457(5)Å b=26.456(4)Å c=10.4560(10)Å
α=90° β=100.112(8)° γ=90°
C18H26ClNO4
C18H26ClNO4
CrystEngComm (2018) 20, 23 3207
a=11.5582(8)Å b=6.0006(3)Å c=27.226(2)Å
α=90° β=101.111(7)° γ=90°
1,5,3-dithiazepan-3-ol
0.67(C4H9NOS2)
CrystEngComm (2016) 18, 30 5686
a=6.5991(7)Å b=6.9097(7)Å c=8.2602(9)Å
α=109.839(10)° β=95.545(9)° γ=94.714(8)°
2-(1,5,3-dithiazepan-3-yl)propanoic acid
C7H13NO2S2
CrystEngComm (2016) 18, 30 5686
a=6.4993(6)Å b=8.6630(6)Å c=8.5034(5)Å
α=90° β=104.738(7)° γ=90°
2-(1,5,3-dithiazepan-3-yl)acetic acid
C6H11NO2S2,C2H6OS
CrystEngComm (2016) 18, 30 5686
a=6.58182(17)Å b=16.4019(4)Å c=11.5843(4)Å
α=90° β=98.923(3)° γ=90°
3-(1,5,3-dithiazepan-3-yl)-2-phenylpropanoic acid
C13H17NO2S2
CrystEngComm (2016) 18, 30 5686
a=10.5874(4)Å b=10.2833(3)Å c=25.2185(10)Å
α=90.00° β=90.00° γ=90.00°
(S)-(+)-2-(1,5,3-dithiazepan-3-yl)-4-methylpentanoic acid
C10H19NO2S2
CrystEngComm (2016) 18, 30 5686
a=10.6926(6)Å b=10.9871(7)Å c=21.4364(15)Å
α=90.00° β=90.00° γ=90.00°
2-(1,5,3-dithiazepan-3-yl)butanoic acid
C8H15NO2S2
CrystEngComm (2016) 18, 30 5686
a=5.0968(3)Å b=6.7869(3)Å c=16.6360(10)Å
α=78.801(5)° β=87.344(5)° γ=69.141(5)°
3-(1,5,3-dithiazepan-3-yl)propanoic acid
C7H12NO2S2
CrystEngComm (2016) 18, 30 5686
a=4.9212(5)Å b=30.519(2)Å c=6.7336(4)Å
α=90° β=103.709(8)° γ=90°
(S)-(+)-2-(1,5,3-dithiazepan-3-yl)-3-hydroxypropanoic acid
C7H13NO3S2
CrystEngComm (2016) 18, 30 5686
a=6.8616(11)Å b=8.8688(8)Å c=8.9458(10)Å
α=66.923(10)° β=70.122(13)° γ=85.373(10)°
2-(1,5,3-dithiazepan-3-yl)acetic acid
C6H11NO2S2,H2O
CrystEngComm (2016) 18, 30 5686
a=6.6882(3)Å b=8.6039(4)Å c=8.0793(4)Å
α=90° β=94.507(5)° γ=90°
(2<i>S</i>,5<i>R</i>)-2-Isopropyl-5-methyl-7-(5-methylisoxazol-3-yl)cyclohexanespiro-3'-(1,2,4,5,7-tetraoxazocane)
C16H26N2O5
Acta Crystallographica Section C (2019) 75, 10
a=6.4074(4)Å b=8.1772(8)Å c=16.3291(9)Å
α=90° β=99.241(5)° γ=90°